CN115381925A - A kind of cervical repair dressing and preparation method thereof - Google Patents
A kind of cervical repair dressing and preparation method thereof Download PDFInfo
- Publication number
- CN115381925A CN115381925A CN202111647630.4A CN202111647630A CN115381925A CN 115381925 A CN115381925 A CN 115381925A CN 202111647630 A CN202111647630 A CN 202111647630A CN 115381925 A CN115381925 A CN 115381925A
- Authority
- CN
- China
- Prior art keywords
- cervical
- stem cells
- repair dressing
- copies
- repair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000008439 repair process Effects 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title claims description 13
- 210000000130 stem cell Anatomy 0.000 claims abstract description 34
- 210000003679 cervix uteri Anatomy 0.000 claims abstract description 16
- 241000196324 Embryophyta Species 0.000 claims abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 10
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims abstract description 7
- 201000010099 disease Diseases 0.000 claims abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 7
- 206010020880 Hypertrophy Diseases 0.000 claims abstract description 4
- 206010008254 Cervical cyst Diseases 0.000 claims abstract description 3
- 206010008263 Cervical dysplasia Diseases 0.000 claims abstract description 3
- 206010008342 Cervix carcinoma Diseases 0.000 claims abstract description 3
- 208000011767 Sarcoma of cervix uteri Diseases 0.000 claims abstract description 3
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims abstract description 3
- 201000010881 cervical cancer Diseases 0.000 claims abstract description 3
- 208000007951 cervical intraepithelial neoplasia Diseases 0.000 claims abstract description 3
- 201000003505 cervical polyp Diseases 0.000 claims abstract description 3
- 230000003628 erosive effect Effects 0.000 claims abstract description 3
- 241000125183 Crithmum maritimum Species 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 13
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 11
- 241000208818 Helianthus Species 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 210000001215 vagina Anatomy 0.000 claims description 8
- VIZXMHCBZLGUET-UHFFFAOYSA-N sodium gualenate Chemical compound CC(C)C1=CC=C(C)C2=C(S(O)(=O)=O)C=C(C)C2=C1 VIZXMHCBZLGUET-UHFFFAOYSA-N 0.000 claims description 7
- 229950002760 sodium gualenate Drugs 0.000 claims description 7
- 239000004475 Arginine Substances 0.000 claims description 6
- 239000004472 Lysine Substances 0.000 claims description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 6
- 235000020721 horse chestnut extract Nutrition 0.000 claims description 6
- 229920001184 polypeptide Polymers 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 3
- 230000001681 protective effect Effects 0.000 claims description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract description 10
- 210000004027 cell Anatomy 0.000 abstract description 9
- 230000035876 healing Effects 0.000 abstract description 9
- 208000003251 Pruritus Diseases 0.000 abstract description 8
- 230000007803 itching Effects 0.000 abstract description 8
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 230000004054 inflammatory process Effects 0.000 abstract description 6
- 230000008929 regeneration Effects 0.000 abstract description 6
- 238000011069 regeneration method Methods 0.000 abstract description 6
- 206010052428 Wound Diseases 0.000 abstract description 5
- 208000027418 Wounds and injury Diseases 0.000 abstract description 5
- 229960001340 histamine Drugs 0.000 abstract description 5
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 108700012359 toxins Proteins 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 3
- 206010059866 Drug resistance Diseases 0.000 abstract description 2
- 235000010181 horse chestnut Nutrition 0.000 abstract description 2
- 241000157280 Aesculus hippocastanum Species 0.000 abstract 1
- 239000002085 irritant Substances 0.000 abstract 1
- 231100000021 irritant Toxicity 0.000 abstract 1
- 230000003387 muscular Effects 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 19
- 238000012360 testing method Methods 0.000 description 18
- 210000004400 mucous membrane Anatomy 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 238000011056 performance test Methods 0.000 description 8
- 230000003902 lesion Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000037070 skin defense Effects 0.000 description 3
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 108010008978 Chemokine CXCL10 Proteins 0.000 description 2
- 102000006579 Chemokine CXCL10 Human genes 0.000 description 2
- 108010063738 Interleukins Proteins 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 2
- 102000003505 Myosin Human genes 0.000 description 2
- 108060008487 Myosin Proteins 0.000 description 2
- 206010046935 Vaginal odour Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000005313 bioactive glass Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 241001119624 Aesculus chinensis Species 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000005971 DNA damage repair Effects 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010015866 Extravasation Diseases 0.000 description 1
- 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 1
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 description 1
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 210000004241 Th2 cell Anatomy 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 206010069055 Vulvovaginal pain Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 239000010242 baoji Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000036251 extravasation Effects 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000028597 toxin metabolic process Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
技术领域technical field
本发明属于生物医药技术领域,具体涉及一种宫颈修复敷料及其制备方法。The invention belongs to the technical field of biomedicine, and in particular relates to a cervical repair dressing and a preparation method thereof.
背景技术Background technique
宫颈又称子宫颈,是女性生殖系统中重要组织器官之一。女性的自然衰老、不当性生活、清洗护理不当、妊娠分娩避孕等原因均会引起宫颈处的病变。由于宫颈处于阴道深处,宫颈病变较轻时患者不易察觉,检查发现后由于位置较深不方便治疗或者用药。宫颈病变情况比较严重,出现疼痛或者出血等症状时多采用口服药物、涂敷药物或激光、微波等手段进行治疗。但是采用激光、微波等手段进行治疗会对宫颈周围的神经和结缔组织造成累积性损伤,口服药物还可能会损伤胃黏膜、并且口服药物只能起到短暂的治疗,容易反复发作,无论是口服药物治疗还是激光、微波等手段进行治疗都不能起到对宫颈组织的修复再生作用,达到长期治愈的效果。The cervix, also known as the cervix, is one of the important tissues and organs in the female reproductive system. Women's natural aging, improper sex life, improper cleaning and nursing, pregnancy and childbirth contraception and other reasons will cause cervical lesions. Because the cervix is located deep in the vagina, it is difficult for patients to detect cervical lesions when they are mild. After examination, it is inconvenient to treat or take medicine because of the deep location. Cervical lesions are more serious. When symptoms such as pain or bleeding occur, oral medicine, drug application or laser, microwave and other means are often used for treatment. However, laser, microwave and other means of treatment will cause cumulative damage to the nerves and connective tissue around the cervix. Oral medicine may also damage the gastric mucosa, and oral medicine can only provide short-term treatment, and it is easy to relapse. Drug therapy or laser, microwave and other means of treatment can not play a role in the repair and regeneration of cervical tissue, to achieve a long-term healing effect.
现有的治疗宫颈的涂敷药物含有过多的化学成分,容易给阴道以及宫颈处带来较大的刺激感,引起患者的不适,甚至可能引起阴道以及宫颈处过敏现象。中国专利CN202110967993.X公开了一种具有宫颈术后止血功能且防止感染的液体敷料及应用,中国专利CN200810039461.4公开了一种明胶/生物活性玻璃复合海绵敷料及其制备方法,均采用生物活性玻璃促进组织修复,但容易引发结石积累。无法彻底解决上述问题。Existing coating medicines for the treatment of the cervix contain too many chemical components, which are likely to bring greater irritation to the vagina and cervix, causing discomfort to patients, and may even cause allergies to the vagina and cervix. Chinese patent CN202110967993.X discloses a liquid dressing and its application that has hemostatic function after cervical surgery and prevents infection. Chinese patent CN200810039461.4 discloses a gelatin/bioactive glass composite sponge dressing and its preparation method, all of which use bioactive Glass promotes tissue repair but is prone to stone accumulation. The above-mentioned problems cannot be completely solved.
发明内容Contents of the invention
为解决上述技术问题,本发明的第一个方面提供了一种宫颈修复敷料,其制备原料包括七叶树提取物、小球藻提取物和植物干细胞。In order to solve the above technical problems, the first aspect of the present invention provides a cervical repair dressing, the raw materials of which include horse chestnut extract, chlorella extract and plant stem cells.
作为一种优选的技术方案,按重量份计,其制备原料包括0.1-40份七叶树提取物、0.1-30份小球藻提取物和0.1-60份植物干细胞。As a preferred technical solution, in parts by weight, the preparation raw materials include 0.1-40 parts of horse chestnut extract, 0.1-30 parts of chlorella extract and 0.1-60 parts of plant stem cells.
七叶树提取物能够改善受损黏膜组织的血液循坏,加速代谢老化组织及阴道中垃圾的排出,促进肌动蛋白和肌球蛋白的生成,以增加纤维芽细胞数量,使黏膜及肌层紧密有弹性,提高宫颈组织的收缩力进而调整强化其整体形态。Horse chestnut extract can improve the blood circulation of damaged mucosal tissue, accelerate the discharge of metabolic aging tissue and garbage in the vagina, promote the production of actin and myosin, increase the number of fibroblasts, and make the mucosa and muscle layer Tight and elastic, improve the contractility of cervical tissue and then adjust and strengthen its overall shape.
小球藻提取物能够深入肌层,净化并帮助代谢宫颈组织的毒素,清除细胞内的自由基,增强细胞的活力,延缓细胞的衰老,加速受损细胞及DNA的修复与破损黏膜组织再生,能够较好的增强机体免疫性能,形成肌体修复屏障,及时排出体内积液以及毒素,消除因炎症产生的瘙痒感、疼痛感、红肿等不适。Chlorella extract can penetrate deep into the muscle layer, purify and help metabolize toxins in cervical tissue, remove free radicals in cells, enhance cell vitality, delay cell aging, accelerate the repair of damaged cells and DNA and the regeneration of damaged mucosal tissues, It can better enhance the immune function of the body, form a body repair barrier, expel fluids and toxins in the body in time, and eliminate itching, pain, redness and swelling caused by inflammation.
作为一种优选的技术方案,所述制备原料还包括愈创木薁磺酸钠。As a preferred technical solution, the preparation raw materials also include sodium guaiazulene sulfonate.
发明人发现在宫颈修复敷料中加入愈创木薁磺酸钠,能够提高宫颈修复敷料对受损组织的修复再生和抗炎作用,促进受损组织快速愈合,而且还能降低患者的疼痛感。发明人认为可能的原因是愈创木薁磺酸钠能够对白细胞起到对白细胞迁移起到抑制作用,从而提高抗炎效果,能够对宫颈处的毛细血管通透性起到抑制作用,促进肉芽再生,修复受损组织,从而促进伤口愈合,对细胞组胺的释放起到抑制作用从而降低患者的疼痛感。但愈创木薁磺酸钠的加入会造成宫颈修复敷料的粗糙度增大,降低患者给药时的舒适感。The inventors found that adding sodium guaiazulene sulfonate to the cervical repair dressing can improve the repair and regeneration and anti-inflammatory effects of the cervical repair dressing on damaged tissues, promote the rapid healing of damaged tissues, and reduce the pain of patients. The inventors believe that the possible reason is that sodium guaiazulene sulfonate can inhibit the migration of leukocytes, thereby improving the anti-inflammatory effect, inhibiting the permeability of capillaries in the cervix, and promoting granulation. Regenerate, repair damaged tissue, thereby promoting wound healing, and inhibit the release of cellular histamine to reduce the patient's pain. However, the addition of sodium guaiazulene sulfonate will increase the roughness of the cervical repair dressing and reduce the comfort of the patient when administering the drug.
作为一种优选的技术方案,所述制备原料还包括肽类化合物。As a preferred technical solution, the preparation raw materials also include peptide compounds.
作为一种优选的技术方案,所述肽类化合物为精氨酸/赖氨酸多肽。As a preferred technical solution, the peptide compound is an arginine/lysine polypeptide.
发明人发现精氨酸/赖氨酸多肽能够提高整体宫颈修复敷料的凝胶性,使宫颈修复敷料的完整性得到明显提高,能够全面覆盖宫颈的损伤处,并且能够促进宫颈修复敷料对损伤处外渗液的吸收以及代谢垃圾排出体外。精氨酸/赖氨酸多肽还能够较好的提高宫颈修复敷料的润滑度、持水性和给药舒适度,降低宫颈修复敷料的粗糙度,减少在用药时因宫颈修复敷料的粗糙度过大,使宫颈修复敷料的与阴道以及宫颈产生较大的摩擦力,造成患者阴道的疼痛感加剧等情况。The inventors found that the arginine/lysine polypeptide can improve the gelation of the overall cervical repair dressing, significantly improve the integrity of the cervical repair dressing, can fully cover the damaged part of the cervix, and can promote the repair of the cervical repair dressing on the damaged part. Absorption of extravasation and excretion of metabolic waste. Arginine/lysine polypeptide can also better improve the lubricity, water holding capacity and comfort of administration of cervical repair dressings, reduce the roughness of cervical repair dressings, and reduce the excessive roughness of cervical repair dressings during medication. , so that the cervical repair dressing will have greater friction with the vagina and cervix, causing the patient's vaginal pain to increase.
作为一种优选的技术方案,所述植物干细胞为海茴香干细胞和/或向日葵干细胞。As a preferred technical solution, the plant stem cells are sea fennel stem cells and/or sunflower stem cells.
作为一种优选的技术方案,所述植物干细胞为海茴香干细胞和向日葵干细胞的混合物。As a preferred technical solution, the plant stem cells are a mixture of sea fennel stem cells and sunflower stem cells.
作为一种优选的技术方案,所述植物干细胞为海茴香干细胞和向日葵干细胞的混合物,所述海茴香干细胞和向日葵干细胞之间的重量比为(1-10):1。As a preferred technical solution, the plant stem cells are a mixture of sea fennel stem cells and sunflower stem cells, and the weight ratio between sea fennel stem cells and sunflower stem cells is (1-10):1.
作为一种优选的技术方案,所述植物干细胞为海茴香干细胞和向日葵干细胞的混合物,所述海茴香干细胞和向日葵干细胞之间的重量比为(5-7):1。As a preferred technical solution, the plant stem cells are a mixture of sea fennel stem cells and sunflower stem cells, and the weight ratio between sea fennel stem cells and sunflower stem cells is (5-7):1.
海茴香干细胞强韧宫颈组织,在受损黏膜组织表面形成保护膜,减少受损黏膜组织与病菌、代谢物之间的接触,允许气体的渗透,避免再次交叉感染,促进代谢产物的排出、消除宫颈组织的充血,改善受损黏膜组织的修护环境,通过减少组胺释放,强效缓解炎症引起的疼痛、以及刺激过敏反应,防止反复炎症引起的组织损伤、病变及老化,并且还能清除阴道异味。但是发明人发现海茴香干细胞在组织中的渗透效果较差,推进阴道中的修复敷料不能充分发挥其作用,发明人意外发现通过加入一定量的向日葵干细胞,不仅能够促进海茴香干细胞在组织中的渗透作用,而且能促进细胞对宫颈修复敷料的吸收、修复弹力纤维,使内外阴部的拉紧力和收缩力增强,提高抵抗病菌入侵的能力,还能够提高整体药物的抑菌抗炎性能。Sea fennel stem cells strengthen the cervical tissue, form a protective film on the surface of the damaged mucosal tissue, reduce the contact between the damaged mucosal tissue, bacteria and metabolites, allow the penetration of gas, avoid re-infection, and promote the discharge and elimination of metabolites Congestion of cervical tissue improves the repair environment of damaged mucosal tissue. By reducing the release of histamine, it effectively relieves the pain caused by inflammation and stimulates allergic reactions, prevents tissue damage, lesions and aging caused by repeated inflammation, and can also clear Vaginal odor. However, the inventor found that the penetration effect of sea fennel stem cells in tissues was poor, and the repair dressing that was pushed into the vagina could not fully exert its effect. Penetration, and can promote the absorption of cells to cervical repair dressings, repair elastic fibers, enhance the tension and contraction of the inner and outer genitals, improve the ability to resist the invasion of germs, and improve the antibacterial and anti-inflammatory properties of the overall drug.
发明人认为宫颈修复敷料内在的作用机理是宫颈修复敷料作用于宫颈病变处时,会使细胞能量ATP升高,角质细胞生长因子升高,肌动蛋白和肌球蛋白的生成能力提高,受损细胞与粘膜组织再生能力提高,促进肉芽和上皮组织的形成,提高宫颈组织的强韧度和收缩力,加速黏膜组织的微循坏和毛细管的重建,从而降低宫颈组织的充血现象;使病源微生物细胞自溶死亡,同时降低受损黏膜组织与病菌接触时间和宫颈组织的病变可能性,使细胞的IL-8&TNF-α的生成和IL-2&IL-6的基因表达降低,肥大细胞与Th2细胞的活化能力增强,COX-2酶的活性、B细胞与T细胞的活化和NF-κB活性降低,从而使细胞组胺的释放降低,宫颈慢性炎症与过敏反应的情况减少,提高免疫调节作用,根除宫颈肥大症状,提高巨噬细胞的吞噬活性,增强成纤维细胞的DNA损伤修复能力,促进受损黏膜组织的血液循坏,从而提高宫颈组织的毒素代谢能力,排出腺体深部滞留的黏液。The inventor believes that the internal mechanism of the cervical repair dressing is that when the cervical repair dressing acts on the cervical lesion, it will increase the cell energy ATP, increase the keratinocyte growth factor, increase the production capacity of actin and myosin, and damage the Improve the regeneration ability of cells and mucosal tissue, promote the formation of granulation and epithelial tissue, improve the toughness and contractility of cervical tissue, accelerate the microcirculation of mucosal tissue and the reconstruction of capillaries, thereby reducing the hyperemia of cervical tissue; make pathogenic microorganisms Cell autolysis and death, while reducing the contact time between damaged mucosal tissue and germs and the possibility of cervical tissue lesions, the generation of IL-8&TNF-α and the gene expression of IL-2&IL-6 in cells are reduced, and the relationship between mast cells and Th2 cells The activation ability is enhanced, the activity of COX-2 enzyme, the activation of B cells and T cells, and the activity of NF-κB are reduced, thereby reducing the release of cellular histamine, reducing the chronic inflammation and allergic reactions of the cervix, improving the immune regulation, and eradicating Symptoms of cervical hypertrophy, improve the phagocytic activity of macrophages, enhance the DNA damage repair ability of fibroblasts, promote the blood circulation of damaged mucosal tissues, thereby improving the toxin metabolism ability of cervical tissues, and discharge the mucus retained in the deep gland.
本发明的第二个方面提供了所述的宫颈修复敷料的制备方法,所述宫颈修复敷料的制备方法为,将制备原料在20-80℃混合均匀,过滤出料,即得。The second aspect of the present invention provides the preparation method of the cervical repair dressing. The preparation method of the cervical repair dressing is as follows: mixing the raw materials uniformly at 20-80° C., and filtering out the material to obtain the product.
本发明的第三个方面提供了所述的宫颈修复敷料应用于宫颈糜烂、宫颈息肉、宫颈肥大、宫颈囊肿、宫颈上皮内瘤变、宫颈癌和子宫颈肉瘤的宫颈疾病治疗中。The third aspect of the present invention provides that the cervical repair dressing is used in the treatment of cervical erosion, cervical polyps, cervical hypertrophy, cervical cysts, cervical intraepithelial neoplasia, cervical cancer and cervical sarcoma.
本发明的第四个方面提供了所述的宫颈修复敷料在宫颈疾病治疗中的使用方法为:将宫颈修复敷料分装于妇科用推进器中,使用时打开推进器保护盖,将推进器的推管深入阴道内部,推管口到达宫颈时推动推杆挤出宫颈修复敷料覆盖于宫颈处。The fourth aspect of the present invention provides the method of using the cervical repair dressing in the treatment of cervical diseases: distributing the cervical repair dressing into a gynecological pusher, opening the protective cover of the pusher during use, and inserting the pusher The push tube goes deep into the vagina, and when the push tube reaches the cervix, push the push rod to extrude the cervical repair dressing to cover the cervix.
另外,如果没有其它说明,所用原料都是市售得到的。In addition, all raw materials used are commercially available unless otherwise stated.
有益效果:Beneficial effect:
(1)本技术方案中的宫颈修复敷料能够深入肌层,净化并帮助代谢宫颈组织的毒素、消除宫颈组织的充血,有效消除因炎症产生的瘙痒感、红肿等不适,对细胞组胺的释放起到抑制作用从而降低患者的疼痛感,加速受损组织和毛细血管的修复再生,促进受损组织快速愈合,从而促进伤口愈合。(1) The cervical repair dressing in this technical solution can penetrate deep into the muscle layer, purify and help metabolize toxins in cervical tissue, eliminate congestion of cervical tissue, effectively eliminate itching, redness and swelling caused by inflammation, and inhibit the release of cellular histamine. It plays an inhibitory role to reduce the pain of patients, accelerate the repair and regeneration of damaged tissues and capillaries, and promote the rapid healing of damaged tissues, thereby promoting wound healing.
(2)本技术方案中的宫颈修复敷料能改善受损黏膜组织的修护环境,防止反复炎症引起的组织损伤、病变及老化,并且还能清除阴道异味。(2) The cervical repair dressing in the technical solution can improve the repair environment of damaged mucosal tissue, prevent tissue damage, pathological changes and aging caused by repeated inflammation, and can also remove vaginal odor.
(3)本技术方案中的宫颈修复敷料能够修复弹力纤维,促进胶原蛋白的形成使肌肤更加紧密,提升肌体的防御能力,使内外阴收紧增强抵抗病菌入侵的的能力,提升拉紧和收缩力,重塑肌体架构。(3) The cervical repair dressing in this technical solution can repair elastic fibers, promote the formation of collagen, make the skin tighter, improve the defense ability of the body, tighten the inner and outer genitals, enhance the ability to resist the invasion of germs, and improve tension and contraction Force, reshape the body structure.
(4)本技术方案中的宫颈修复敷料为纯天然配方,自然无刺激性,具有较高的给药舒适度,采用推进器给药的方式,无任何副作用不会使肌体产生耐药性,对宫颈疾病具有较好的治愈效果。(4) The cervical repair dressing in this technical solution is a pure natural formula, which is naturally non-irritating and has a high degree of comfort in administration. It adopts the mode of propeller administration without any side effects and will not cause the body to develop drug resistance. It has a good curative effect on cervical diseases.
附图说明Description of drawings
图1.本发明中瘙痒感测试结果图;Fig. 1. itching sensation test result figure among the present invention;
图2.本发明伤口愈合测试效果图;Fig. 2. wound healing test effect diagram of the present invention;
图3.本发明皮肤防御能力测试效果图;Fig. 3. skin defense ability test rendering of the present invention;
图4.本发明抑制内毒素引起的白介素IL1-β表达结果;Fig. 4. The present invention inhibits the expression result of interleukin IL1-β caused by endotoxin;
图5.本发明抑制内毒素引起的趋化因子CXCL10表达结果;Fig. 5. The present invention inhibits the expression result of chemokine CXCL10 caused by endotoxin;
图6.本发明安全指标检测结果。Fig. 6. The detection result of the safety index of the present invention.
具体实施方式Detailed ways
实施例Example
说明:下述实施例中A~G的具体指代如下。Explanation: The specific designations of A to G in the following examples are as follows.
A:海茴香干细胞,所述海茴香(crithmum maritimum)干细胞购于中国香港潮牛国际集团;A: sea fennel stem cells, the sea fennel (crithmum maritimum) stem cells were purchased from Chaoniu International Group in Hong Kong, China;
B:向日葵干细胞,所述向日葵(Helianthus annuus L.)干细胞购于中南源品干细胞科技园;B: sunflower stem cells, the sunflower (Helianthus annuus L.) stem cells were purchased from Zhongnan Yuanpin Stem Cell Technology Park;
C:七叶树提取物,所述七叶树(Aesculus chinensis Bunge)提取物购于宝鸡市方晟生物开发有限公司;C: horse chestnut extract, described horse chestnut (Aesculus chinensis Bunge) extract is purchased from Baoji Fangsheng Biological Development Co., Ltd.;
D:小球藻提取物,所述小球藻提取物购于西安瑞尔丽生物工程有限公司;D: Chlorella extract, which was purchased from Xi'an Ruierli Biological Engineering Co., Ltd.;
E:精氨酸/赖氨酸多肽,所述精氨酸/赖氨酸多肽购于赛尔瑞成(北京)生命科学技术有限公司;E: arginine/lysine polypeptide, the arginine/lysine polypeptide was purchased from Saier Ruicheng (Beijing) Life Science Technology Co., Ltd.;
F:愈创木薁磺酸钠,所述愈创木薁磺酸钠购于武汉卡布达化工有限公司;F: sodium guaiazulene sulfonate, the sodium guaiazulene sulfonate was purchased from Wuhan Kabuda Chemical Co., Ltd.;
G:甘草提取物,所述甘草(Glycyrrhiza uralensis Fisch.)提取物购于IDbio。G: licorice extract, the licorice (Glycyrrhiza uralensis Fisch.) extract was purchased from IDbio.
表1.实施例1~实施例11提供的宫颈修复敷料的原料组成Table 1. The raw material composition of the cervical repair dressing provided by
性能测试Performance Testing
性能测试一performance test one
刺激性测试:将实施例1~实施例11中所制备宫颈敷料用于动物表皮进行刺激性测试,无刺激性的继续进行后续测试。Irritation test: The cervical dressings prepared in Examples 1 to 11 were applied to animal epidermis to conduct an irritation test, and the non-irritating ones continued to conduct subsequent tests.
结果表明:实施例1、2、5、7、8、9、10和11可以通过刺激性测试,能够进行后续测试。The results show that: Examples 1, 2, 5, 7, 8, 9, 10 and 11 can pass the irritation test and can carry out follow-up tests.
性能测试二Performance test two
瘙痒感消除测试:选取妇科疾病患者60人平均分成两组,分别为空白组和测试组,将实施例1中的原料制备成宫颈修复敷料用于测试组志愿者,空白组志愿者使用安慰剂敷料,每天使用1次连续使用3天,每个组独立观察统计,患者对瘙痒感进行记录并评分,3天之后统计评分结果(0~10分,瘙痒感越强分值越高)见图1,测试组志愿者使用实施例1中的宫颈修复敷料(即图1中的私护凝胶)后均具有明显的止痒效果;空白组志愿者的瘙痒感无明显变化。Itching sensation elimination test: Select 60 patients with gynecological diseases and divide them into two groups on average, namely the blank group and the test group. The raw materials in Example 1 are prepared into cervical repair dressings for the test group volunteers, and the blank group volunteers use placebo The dressing was used once a day for 3 consecutive days. Each group was independently observed and counted. The patients recorded and scored the itching sensation. After 3 days, the statistical scoring results (0-10 points, the stronger the itching sensation, the higher the score) are shown in the figure 1. Volunteers in the test group had obvious antipruritic effect after using the cervical repair dressing in Example 1 (that is, the personal care gel in Figure 1); the itching sensation of the volunteers in the blank group did not change significantly.
性能测试三performance test three
治愈效果测试:实施例1、2、5、7、8、9、10和11可以通过刺激性测试,进一步进行宫颈疾病治愈效果测试,其中实施例1、2的治愈效果最优,舒适度高,实施例5、7、8、9、10和11的治愈效果一般,舒适度较高。Healing effect test: Examples 1, 2, 5, 7, 8, 9, 10 and 11 can pass the irritation test, and further carry out the cervical disease healing effect test, wherein the curing effect of
性能测试四Performance Test Four
伤口愈合测试:将实施例1中所制备的宫颈修复敷料用于实验组的动物表皮伤口处,空白对照组使用安慰剂敷料用于动物表皮伤口处,每天使用两次,连续使用9天,进行伤口愈合情况统计,如图2所示,实验组动物表皮伤口明显愈合,空白对照组动物表皮伤口愈合比较慢且不明显。Wound healing test: the cervical repair dressing prepared in Example 1 was applied to the epidermal wound of the experimental group, and the placebo dressing was applied to the epidermal wound of the animal in the blank control group. It was used twice a day for 9 consecutive days. Statistics on wound healing, as shown in Figure 2, the epidermal wounds of the animals in the experimental group healed obviously, while the epidermal wounds of the animals in the blank control group healed slowly and not obviously.
性能测试五Performance Test Five
将实施例1中所制备的宫颈敷料进行皮肤防御能力测试,结果见图3。可见所得宫颈辅料具有显著的皮肤防御提升能力。The cervical dressing prepared in Example 1 was tested for skin defense ability, and the results are shown in FIG. 3 . It can be seen that the obtained cervical auxiliary material has a significant ability to improve skin defense.
性能测试六Performance Test Six
如图4和图5所示,实施例1中的宫颈修复敷料能显著抑制内毒素引起的白介素IL1-β和趋化因子CXCL10过度表达。As shown in Figures 4 and 5, the cervical repair dressing in Example 1 can significantly inhibit the overexpression of interleukin IL1-β and chemokine CXCL10 induced by endotoxin.
其中,HPV凝胶即对应实施例1所得的宫颈修复敷料。Wherein, the HPV gel corresponds to the cervical repair dressing obtained in Example 1.
性能测试七Performance Test Seven
按照《化妆品安全技术规范》2015版,对实施例1制得的宫颈修复敷料进行测试,测试结果见图6。According to the 2015 edition of the "Safety and Technical Standards for Cosmetics", the cervical repair dressing prepared in Example 1 was tested, and the test results are shown in Figure 6.
性能测试八Performance Test Eight
将实施例1提供的宫颈修复敷料平行设置3份,分别置于5℃,25℃,40℃放置15天,恢复至室温(20℃)后观察到无性状差异,耐温稳定。Three copies of the cervical repair dressing provided in Example 1 were set up in parallel, and placed at 5°C, 25°C, and 40°C for 15 days respectively. After returning to room temperature (20°C), no difference in properties was observed, and the temperature resistance was stable.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111647630.4A CN115381925A (en) | 2021-12-30 | 2021-12-30 | A kind of cervical repair dressing and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111647630.4A CN115381925A (en) | 2021-12-30 | 2021-12-30 | A kind of cervical repair dressing and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115381925A true CN115381925A (en) | 2022-11-25 |
Family
ID=84113693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111647630.4A Pending CN115381925A (en) | 2021-12-30 | 2021-12-30 | A kind of cervical repair dressing and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115381925A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116327886A (en) * | 2023-04-21 | 2023-06-27 | 广东省女性健康研究院 | Gynecological vaginal mucosa repair gel |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108309869A (en) * | 2018-04-29 | 2018-07-24 | 佛山云裳化妆品有限公司 | It is a kind of to have effects that the skin care compositions of skin repair and its application |
| CN110368447A (en) * | 2019-08-09 | 2019-10-25 | 吉安市御美丽健康产业股份有限公司 | A kind of gynaecology's reparation gel preparation and its preparation method and application containing sodium azulenesulfonate |
| CN111631991A (en) * | 2019-03-01 | 2020-09-08 | 王飞 | Private nursing lotion |
| CN113230390A (en) * | 2021-01-29 | 2021-08-10 | 南京北极光生物科技有限公司 | Composition, vaginal lotion and application of vaginal lotion in gynecological mucosal injury repair |
-
2021
- 2021-12-30 CN CN202111647630.4A patent/CN115381925A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108309869A (en) * | 2018-04-29 | 2018-07-24 | 佛山云裳化妆品有限公司 | It is a kind of to have effects that the skin care compositions of skin repair and its application |
| CN111631991A (en) * | 2019-03-01 | 2020-09-08 | 王飞 | Private nursing lotion |
| CN110368447A (en) * | 2019-08-09 | 2019-10-25 | 吉安市御美丽健康产业股份有限公司 | A kind of gynaecology's reparation gel preparation and its preparation method and application containing sodium azulenesulfonate |
| CN113230390A (en) * | 2021-01-29 | 2021-08-10 | 南京北极光生物科技有限公司 | Composition, vaginal lotion and application of vaginal lotion in gynecological mucosal injury repair |
Non-Patent Citations (2)
| Title |
|---|
| 国家市场监督管理总局广告监督管理司: "干细胞美容抗衰"广告宣传虚假违法", Retrieved from the Internet <URL:https://www.samr.gov.cn/cms_files/filemanager/samr/www/samrnew/ggjgs/sjdt/gzdt/202108/t20210803_333315.html> * |
| 网易: "墨菊提取液的开发与应用", pages 2, Retrieved from the Internet <URL:http://hebei.news.163.com/14/0716/15/A19KP6TH02790BCQ.html> * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116327886A (en) * | 2023-04-21 | 2023-06-27 | 广东省女性健康研究院 | Gynecological vaginal mucosa repair gel |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103272153B (en) | A kind of antibacterial gel and preparation method thereof | |
| CN103316261B (en) | Medical antibacterial liquid and preparation method thereof | |
| CN101780031B (en) | Induced gel for repairing skin wound or cervical mucosa | |
| CN102058781A (en) | Traditional Chinese medicinal film agent for treating burns and scalds | |
| CN101129787A (en) | Burn cream | |
| CN105250696A (en) | Traditional Chinese medicine gel capable of promoting skin wound to heal and preparation method of traditional Chinese medicine gel | |
| CN115381925A (en) | A kind of cervical repair dressing and preparation method thereof | |
| CN113616714A (en) | High-selenium anti-HPV (human papillomavirus) biological protein gel dressing and preparation method thereof | |
| CN103007034B (en) | Traditional Chinese medicine composition used for treatment of residual second-degree burn wound, and preparation method thereof | |
| CN116672401A (en) | Herbal hpv gynecological antibacterial gel and preparation method thereof | |
| CN104623457B (en) | Vagina-shrinking expellent nti-freckle gelling agent and preparation method thereof | |
| CN115444912A (en) | Composition for treating acne and preparation method thereof | |
| CN101062085B (en) | Condyloma acuminata treating medicine | |
| CN112121146B (en) | A topical gel for treating skin wound, and its preparation method | |
| CN114344452A (en) | Ointment for treating scar burn and preparation method and application thereof | |
| CN115844940B (en) | External ointment for treating cervicitis and preparation method thereof | |
| RU2626673C1 (en) | Means for treatment of skin and mucosa diseases, for local use, which is anti-inflammatory, anti-bacterial, antiviral, wound-healung, anti-fungal | |
| CN110433284A (en) | A kind of composition that treating cervicitis, gelling agent and preparation method thereof | |
| CN1237426A (en) | Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer | |
| RU2782695C1 (en) | Composition for external use "septisol" | |
| CN101869578B (en) | External liniment for drawing pus out and diminishing inflammation | |
| CN110433236B (en) | Traditional Chinese medicine composition for promoting wound healing and preparation method and application thereof | |
| CN101095752B (en) | Chinese traditional medicine for treating burn and scald | |
| Bercovitz | Cancer in Hainan, China: A Preliminary Statistical Study of 131 Operations with Special Reference to Age Incidence, Anatomical Distribution, and Etiology | |
| CN105250711A (en) | Traditional Chinese medicine composition for treating abdominal incision induration after cesarean delivery operation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20230106 Address after: Room 501, 502 and 503, Floor 5, No. 11, Lane 2999, Hutai Road, Baoshan District, Shanghai, 2019 Applicant after: Shanghai Borunke Biotechnology Co.,Ltd. Address before: 518000 Unit 2202, Building B, Smart Home, No. 76, Baohe Avenue, Baolong Community, Baolong Street, Longgang District, Shenzhen, Guangdong Applicant before: GUORUN BIOTECHNOLOGY (SHENZHEN) Co.,Ltd. |